Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.
Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer. BMC Cancer. 2018 01 22; 18(1):87.
View in:
PubMed
subject areas
Aged
Animals
Antigens, Neoplasm
Caenorhabditis elegans
CD8-Positive T-Lymphocytes
Chickens
Female
Gene Expression Regulation, Neoplastic
Genome
High-Throughput Nucleotide Sequencing
Humans
Macrophages
Middle Aged
Mutation
Neoplasm Recurrence, Local
Neoplastic Stem Cells
Ovarian Neoplasms
Platinum
authors with profiles
Jeffrey E. Hammerbacher